Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Interferon-β is an established treatment for patients with multiple sclerosis (MS) but its mechanisms of action are not well understood. Viral infections are a known trigger of MS relapses. Toll-like receptors (TLRs) are key components of the innate immune system, which sense conserved structures of...
Guardado en:
Autores principales: | Katja Derkow, Jakob M J Bauer, Michael Hecker, Brigitte K Paap, Madhan Thamilarasan, Dirk Koczan, Eckart Schott, Katrin Deuschle, Judith Bellmann-Strobl, Friedemann Paul, Uwe K Zettl, Klemens Ruprecht, Seija Lehnardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb1df074a4e941838c7b5bfc2b300752 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.
por: Simona E Budulac, et al.
Publicado: (2012) -
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Anastazja M. Gorecki, et al.
Publicado: (2021) -
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.
por: Isabelle E Vincent, et al.
Publicado: (2011) -
BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells
por: Alexis Combes, et al.
Publicado: (2017) -
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.
por: Yonggang Ma, et al.
Publicado: (2012)